We demonstrated that, in addition to acting as a potential colon cancer biomarker, ALDH1B1 may significantly contribute to the development of tumors by modulating canonical Wnt/β-catenin, Notch and PI3K/Akt signaling pathways. The gene discussed is ALDH1B1; the disease is malignant colon neoplasm.